ISLAMABAD: Federal Minster Aamer Mehmood Kiani and Chief Executive Officer (CEO) Drug Regulatory Authority of Pakistan (DRAP) Asim Rauf visited UDL distribution along with area Federal Inspector of Drugs.
“Stock of GlaxoSmithkline was seized on unauthorized increase in the price,” said a statement on Thursday.
In continuation of the crackdown against companies for unauthorized increase in the prices of their medicines, DRAP has been directed to take strict action by Federal Minister of Health.
Across the country, inspectors of DRAP are involved in active surveillance.
Various medicines were seized in Lahore, Karachi, Islamabad, Faisalabad and Peshawar.
Stock of overpriced medicine seized in Faisalabad from IBL distribution. Around 39 medicines with unauthorized increase in pricing were seized from various pharmacies in Lahore.
Karachi’s MM traders raided by Federal Inspector of Drugs. Huge stock of overpriced medicine seized. Action against unauthorized increase in prices of medicines:
DRAP seized stocks from various medical stores in Peshawar.
Balouch enterprises raided in Multan: seizure of stock of overpriced medicine.
Federal Minister said that legal action will be taken against those involved in unauthorized increase in prices of medicine.
He added that reduction in prices of 395 prices was notified and strict compliance of the companies shall be ensured.
The crackdown will continue against those companies who are not selling medicine on approved prices.